Bausch Health stock drops after suing Amneal Pharma over Xifaxan generic

Published on 8 Apr 2024 on Seeking Alpha

Bausch Health's stock falls 7% as it files a patent lawsuit against a generic version of its bowel...

Read the rest of the article

Start tracking your investments with Statfolio

Bausch Health (BHC) experienced a 7.4% increase as an appeals court ruled in favor of the company...

Seeking Alpha 11 Apr 2024

On Thursday, Bausch Health Companies Inc. (NYSE:BHC) received a reaffirmation of a Buy rating and...

Investing.com 11 Apr 2024

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its subsidiary Salix Pharmaceuticals announc...

Investing.com 11 Apr 2024

The shares of pharma stock Bausch Health Companies Inc (NYSE:BHC) have taken a tumble since their...

Schaeffer's Investment Research via Yahoo Finance 10 Apr 2024

Investing.com 8 Apr 2024

Bausch Health's stock falls 7% as it files a patent lawsuit against a generic version of its bowe...

Seeking Alpha 8 Apr 2024

Taking full advantage of the stock market and investing with confidence are common goals for new ...

Zacks via Yahoo Finance 3 Apr 2024

Bausch Health Companies Inc. (NYSE: BHC )(TSX:BHC) has announced the inclusion of UCERIS®...

Investing.com 3 Apr 2024

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) has announced the inclusion of UCERIS® (budesoni...

Investing.com 3 Apr 2024

Insight into Chou RRSP Fund (Trades, Portfolio)'s Q4 2023 Investment Moves and Portfolio Adjustme...

GuruFocus.com via Yahoo Finance 1 Apr 2024